López-Cano Gómez María, Laguna Del Estal Pedro, García Montero Pablo, Gil Navarro Manuel, Castañeda Pastor Ana
Servicio de Medicina Interna, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, España.
Gastroenterol Hepatol. 2012 Apr;35(4):229-35. doi: 10.1016/j.gastrohep.2012.01.001. Epub 2012 Feb 24.
To describe the clinical features of pyogenic liver abscesses (PLA) and identify the factors associated with an unfavorable outcome.
We performed a retrospective review of the clinical histories of patients with liver abscess (1996-2009), including those that met the diagnostic criteria for PLA. Outcome was classified as favorable or unfavorable (severe sepsis, distant infectious complications, local complications, intensive care unit admission, admission for>30 days, death, readmission).
There were 54 patients with PLA (65% men), with a mean age of 61 years. Predisposing factors consisted of biliopancreatic disease in 33%, recent admission in 20%, alcoholism in 15%, diabetes mellitus in 15%, a history of gastrointestinal neoplasm in 11% and abdominal surgery in 11%. The cause was cryptogenic in 65%, biliary in 31%, and portal in 4%. Symptoms consisted of fever in 100%, abdominal pain in 65%, vomiting in 37%, enlarged liver in 33%, systemic inflammatory response syndrome in 26%, and jaundice in 9%. Blood and pus cultures were positive in 40% and 65%, respectively. The most frequently isolated microorganisms were E. coli and Streptococcus spp. Percutaneous drainage was performed in 72% (surgical drainage was also performed in 6%), and antibiotic treatment alone was administered in 28%. Outcome was unfavorable in 52% and was associated with greater age (p=0.016), a history of biliopancreatic disease (p=0.007), systemic inflammatory response syndrome at diagnosis (p=0.005), coagulation alterations (p=0.043), aspartate aminotransferase elevation (p=0.033), and biliary etiology (p<0.001).
PLA developed in patients with comorbidity, although most were cryptogenic. The majority of PLA were resolved with antibiotic therapy and percutaneous drainage, without surgery. Mortality was 9%, but half the patients had unfavorable outcome, associated with biliary etiology and some laboratory alterations.
描述化脓性肝脓肿(PLA)的临床特征,并确定与不良预后相关的因素。
我们对肝脓肿患者(1996 - 2009年)的临床病史进行了回顾性研究,包括符合PLA诊断标准的患者。结局分为良好或不良(严重脓毒症、远处感染并发症、局部并发症、入住重症监护病房、住院超过30天、死亡、再次入院)。
有54例PLA患者(65%为男性),平均年龄61岁。易感因素包括胆胰疾病占33%、近期入院占20%、酗酒占15%、糖尿病占15%、胃肠道肿瘤病史占11%、腹部手术史占11%。病因不明者占65%,胆汁源性占31%,门静脉源性占4%。症状包括发热占100%、腹痛占65%、呕吐占37%、肝脏肿大占33%、全身炎症反应综合征占26%、黄疸占9%。血培养和脓液培养阳性率分别为40%和65%。最常分离出的微生物是大肠杆菌和链球菌属。72%的患者进行了经皮引流(6%的患者还进行了手术引流),28%的患者仅接受了抗生素治疗。52%的患者预后不良,且与年龄较大(p = 0.016)、胆胰疾病史(p = 0.007)、诊断时的全身炎症反应综合征(p = 0.005)、凝血功能改变(p = 0.043)、天冬氨酸转氨酶升高(p = 0.033)以及胆汁源性病因(p < 0.001)相关。
PLA在合并症患者中发生,尽管大多数病因不明。大多数PLA通过抗生素治疗和经皮引流得以解决,无需手术。死亡率为9%,但一半患者预后不良,与胆汁源性病因和一些实验室检查异常相关。